Monmouth Junction, New Jersey (NJ) Commercial Physical and Biological Research Companies
Featured companies
Not satisfied? Select a reason•Rate this page•Send feedback
Or try our search form or quick navigation by category and location
Princeton Bio Molecular Research
11 Deerpark Dr # 102E
Monmouth Junction NJ 088521969
(732) 355-9920
Designing and distributing building blocks and screening compounds
Provid Pharmaceuticals Inc is a privately held company in Monmouth Junction, NJ and is a Single Location business.
Whereorg has 58 results under Commercial Physical and Biological Research Companies in Monmouth Junction, NJ.
Narrow down the browsing criteria below to see more companies.
Select a category for location Middlesex, New Jersey
Other locations for category Commercial Physical and Biological Research
- Avenel1
- Carteret19
- Colonia3
- Cranbury72
- Dayton24
- Dunellen4
- East Brunswick64
- Edison99
- Fords2
- Green Brook12
- Helmetta3
Quick navigation
Subcategory
City or suburb
- Avenel1
- Carteret19
- Colonia3
- Cranbury72
- Dayton24
- Dunellen4
- East Brunswick64
- Edison99
- Fords2
- Green Brook12
- Helmetta3
- Highland Park14
- Iselin27
- Jamesburg9
- Keasbey1
- Kendall Park2
- Laurence Harbor3
- Metuchen26
- Middlesex28
- Monroe Township1
- Monroe Twp9
- New Brunswick76
- North Brunswick45
- Old Bridge10
- Parlin3
- Perth Amboy12
- Piscataway93
- Plainsboro32
- Sayreville18
- South Amboy4
- South Plainfield54
- South River7
- Woodbridge18
Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020